The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
[HTML][HTML] Multi-system inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and …
NA Nakra, DA Blumberg, A Herrera-Guerra… - Children, 2020 - mdpi.com
Children | Free Full-Text | Multi-System Inflammatory Syndrome in Children (MIS-C)
Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical …
Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical …
[HTML][HTML] Multicenter epidemiologic study of coronavirus disease–associated mucormycosis, India
Abstract During September–December 2020, we conducted a multicenter retrospective
study across India to evaluate epidemiology and outcomes among cases of coronavirus …
study across India to evaluate epidemiology and outcomes among cases of coronavirus …
Tocilizumab for treatment of mechanically ventilated patients with COVID-19
EC Somers, GA Eschenauer, JP Troost… - Clinical Infectious …, 2021 - academic.oup.com
Background Severe coronavirus disease 2019 (COVID-19) can manifest in rapid
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
decompensation and respiratory failure with elevated inflammatory markers, consistent with …
COVID-19-associated candidiasis (CAC): an underestimated complication in the absence of immunological predispositions?
The recent global pandemic of COVID-19 has predisposed a relatively high number of
patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing …
patients to acute respiratory distress syndrome (ARDS), which carries a risk of developing …
Mucormycosis in patients with COVID‐19: a cross‐sectional descriptive multicentre study from Iran
Purpose The aim of the study was to report clinical features, contributing factors and
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …
Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic
M Nucci, G Barreiros, LF Guimarães… - Mycoses, 2021 - Wiley Online Library
Background The incidence of candidemia in our hospital has been stable over an 18‐year
period (1.3 episodes per 1000 admissions). Since March 2020, we have observed an …
period (1.3 episodes per 1000 admissions). Since March 2020, we have observed an …
Coronavirus disease 2019–associated invasive fungal infection
JW Baddley, GR Thompson III… - Open forum …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) can become complicated by secondary
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …
invasive fungal infections (IFIs), stemming primarily from severe lung damage and …
The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic
EE Seagle, BR Jackson, SR Lockhart… - Clinical Infectious …, 2022 - academic.oup.com
Background The COVID-19 pandemic has resulted in unprecedented healthcare
challenges, and COVID-19 has been linked to secondary infections. Candidemia, a fungal …
challenges, and COVID-19 has been linked to secondary infections. Candidemia, a fungal …
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
A subset of patients with severe COVID-19 develop profound inflammation and multi-organ
dysfunction consistent with a “Cytokine Storm Syndrome”(CSS). In this review we compare …
dysfunction consistent with a “Cytokine Storm Syndrome”(CSS). In this review we compare …